| Year |
Citation |
Score |
| 2016 |
Sundaramurthy S, Annamalai B, Samuvel DJ, Shippenberg TS, Jayanthi LD, Ramamoorthy S. Modulation of serotonin transporter function by kappa-opioid receptor ligands. Neuropharmacology. PMID 27743931 DOI: 10.1016/J.Neuropharm.2016.10.011 |
0.321 |
|
| 2014 |
Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, ... ... Shippenberg TS, et al. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 86: 228-40. PMID 25107591 DOI: 10.1016/J.Neuropharm.2014.07.016 |
0.766 |
|
| 2013 |
Kuzmin A, Chefer V, Bazov I, Meis J, Ögren SO, Shippenberg T, Bakalkin G. Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment. Translational Psychiatry. 3: e310. PMID 24105441 DOI: 10.1038/Tp.2013.72 |
0.343 |
|
| 2013 |
Chefer VI, Bäckman CM, Gigante ED, Shippenberg TS. Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2623-31. PMID 23921954 DOI: 10.1038/Npp.2013.171 |
0.356 |
|
| 2013 |
Tejeda HA, Counotte DS, Oh E, Ramamoorthy S, Schultz-Kuszak KN, Bäckman CM, Chefer V, O'Donnell P, Shippenberg TS. Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1770-9. PMID 23542927 DOI: 10.1038/Npp.2013.76 |
0.742 |
|
| 2012 |
Tejeda HA, Shippenberg TS, Henriksson R. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. Cellular and Molecular Life Sciences : Cmls. 69: 857-96. PMID 22002579 DOI: 10.1007/s00018-011-0844-x |
0.667 |
|
| 2011 |
Chefer V, Meis J, Wang G, Kuzmin A, Bakalkin G, Shippenberg T. Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release. Addiction Biology. 16: 229-37. PMID 21182572 DOI: 10.1111/J.1369-1600.2010.00272.X |
0.31 |
|
| 2010 |
Tejeda HA, Chefer VI, Zapata A, Shippenberg TS. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat. Psychopharmacology. 210: 231-40. PMID 20232058 DOI: 10.1007/s00213-010-1799-6 |
0.687 |
|
| 2009 |
Chefer VI, Denoroy L, Zapata A, Shippenberg TS. Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms. The European Journal of Neuroscience. 30: 272-8. PMID 19614973 DOI: 10.1111/j.1460-9568.2009.06827.x |
0.345 |
|
| 2009 |
Shippenberg TS, Chefer VI, Thompson AC. Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biological Psychiatry. 65: 169-74. PMID 18950747 DOI: 10.1016/j.biopsych.2008.09.009 |
0.354 |
|
| 2009 |
Chefer VI, Shippenberg TS. Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 887-98. PMID 18704097 DOI: 10.1038/Npp.2008.128 |
0.467 |
|
| 2008 |
Shippenberg TS, LeFevour A, Chefer VI. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. Cns & Neurological Disorders Drug Targets. 7: 442-53. PMID 19128202 DOI: 10.2174/187152708786927813 |
0.345 |
|
| 2008 |
Gehrke BJ, Chefer VI, Shippenberg TS. Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum. Psychopharmacology. 197: 509-17. PMID 18246329 DOI: 10.1007/s00213-007-1067-6 |
0.375 |
|
| 2008 |
Butt C, Alptekin A, Shippenberg T, Oz M. Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. Journal of Neurochemistry. 105: 1235-43. PMID 18194436 DOI: 10.1111/J.1471-4159.2008.05225.X |
0.335 |
|
| 2008 |
Chandran JS, Lin X, Zapata A, Höke A, Shimoji M, Moore SO, Galloway MP, Laird FM, Wong PC, Price DL, Bailey KR, Crawley JN, Shippenberg T, Cai H. Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiology of Disease. 29: 505-14. PMID 18187333 DOI: 10.1016/J.Nbd.2007.11.011 |
0.343 |
|
| 2008 |
Schepers RJ, Mahoney JL, Shippenberg TS. Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception. Pain. 136: 320-30. PMID 17764840 DOI: 10.1016/j.pain.2007.07.010 |
0.379 |
|
| 2007 |
Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, Jaligam V, Oz M, Jayanthi LD, Samuvel DJ, Ramamoorthy S, Shippenberg TS. Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. The Journal of Biological Chemistry. 282: 35842-54. PMID 17923483 DOI: 10.1074/Jbc.M611758200 |
0.739 |
|
| 2007 |
Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Molecular Pharmacology. 71: 1222-32. PMID 17267664 DOI: 10.1124/Mol.106.027763 |
0.74 |
|
| 2007 |
Barbier E, Zapata A, Oh E, Liu Q, Zhu F, Undie A, Shippenberg T, Wang JB. Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1774-82. PMID 17203012 DOI: 10.1038/Sj.Npp.1301301 |
0.381 |
|
| 2006 |
Doyon WM, Howard EC, Shippenberg TS, Gonzales RA. Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration. Neuropharmacology. 51: 487-96. PMID 16781738 DOI: 10.1016/J.Neuropharm.2006.04.005 |
0.334 |
|
| 2006 |
Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America. 103: 2938-42. PMID 16477003 DOI: 10.1073/pnas.0511159103 |
0.348 |
|
| 2006 |
Chefer VI, Zapata A, Shippenberg TS, Bungay PM. Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. Journal of Neuroscience Methods. 155: 187-93. PMID 16466808 DOI: 10.1016/j.jneumeth.2005.12.018 |
0.364 |
|
| 2006 |
Chefer VI, Shippenberg TS. Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens. The European Journal of Neuroscience. 23: 229-38. PMID 16420432 DOI: 10.1111/j.1460-9568.2005.04525.x |
0.379 |
|
| 2005 |
Chefer VI, Czyzyk T, Bolan EA, Moron J, Pintar JE, Shippenberg TS. Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5029-37. PMID 15901784 DOI: 10.1523/Jneurosci.0854-05.2005 |
0.737 |
|
| 2005 |
Zapata A, Shippenberg TS. Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels. Neuropharmacology. 48: 43-50. PMID 15617726 DOI: 10.1016/j.neuropharm.2004.09.003 |
0.319 |
|
| 2005 |
Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED, Knapp PE, Scheff SW, Singh IN, Vissel B, Woods AS, Yakovleva T, Shippenberg TS. Pathobiology of dynorphins in trauma and disease. Frontiers in Bioscience : a Journal and Virtual Library. 10: 216-35. PMID 15574363 DOI: 10.2741/1522 |
0.329 |
|
| 2004 |
Chefer VI, Kieffer BL, Shippenberg TS. Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine. Neuroscience. 127: 497-503. PMID 15262338 DOI: 10.1016/J.Neuroscience.2004.05.021 |
0.345 |
|
| 2004 |
Oz M, Woods AS, Shippenberg T, Kaminski RM. Effects of extracellular pH on the dynorphin A inhibition of N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Synapse (New York, N.Y.). 52: 84-8. PMID 15034914 DOI: 10.1002/Syn.20009 |
0.338 |
|
| 2004 |
Oz M, Zakharova I, Dinc M, Shippenberg T. Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. Naunyn-Schmiedeberg's Archives of Pharmacology. 369: 252-9. PMID 14652711 DOI: 10.1007/S00210-003-0838-9 |
0.302 |
|
| 2003 |
Chefer VI, Kieffer BL, Shippenberg TS. Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice. The European Journal of Neuroscience. 18: 1915-22. PMID 14622224 DOI: 10.1046/J.1460-9568.2003.02912.X |
0.375 |
|
| 2002 |
Witkin JM, Gasior M, Schad C, Zapata A, Shippenberg T, Hartman T, Slusher BS. NAALADase (GCP II) inhibition prevents cocaine-kindled seizures. Neuropharmacology. 43: 348-56. PMID 12243764 DOI: 10.1016/S0028-3908(02)00124-7 |
0.315 |
|
| 2002 |
Basile AS, Fedorova I, Zapata A, Liu X, Shippenberg T, Duttaroy A, Yamada M, Wess J. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proceedings of the National Academy of Sciences of the United States of America. 99: 11452-7. PMID 12154229 DOI: 10.1073/Pnas.162371899 |
0.414 |
|
| 2002 |
Chefer VI, Shippenberg TS. Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions. Neuroscience. 112: 907-19. PMID 12088750 DOI: 10.1016/S0306-4522(02)00099-4 |
0.316 |
|
| 2002 |
Zapata A, Shippenberg TS. D(3) receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens. Journal of Neurochemistry. 81: 1035-42. PMID 12065616 DOI: 10.1046/j.1471-4159.2002.00893.x |
0.355 |
|
| 2001 |
Zapata A, Witkin JM, Shippenberg TS. Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses. Neuropharmacology. 41: 351-9. PMID 11522326 DOI: 10.1016/S0028-3908(01)00069-7 |
0.341 |
|
| 2001 |
Shippenberg TS, Chefer VI, Zapata A, Heidbreder CA. Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems. Annals of the New York Academy of Sciences. 937: 50-73. PMID 11458540 DOI: 10.1111/j.1749-6632.2001.tb03558.x |
0.311 |
|
| 2001 |
He M, Sibille E, Benjamin D, Toth M, Shippenberg T. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain Research. 902: 11-7. PMID 11376590 DOI: 10.1016/S0006-8993(01)02271-5 |
0.303 |
|
| 2001 |
Acri JB, Thompson AC, Shippenberg T. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593. Synapse (New York, N.Y.). 39: 343-50. PMID 11169785 DOI: 10.1002/1098-2396(20010315)39:4<343::Aid-Syn1018>3.0.Co;2-Q |
0.558 |
|
| 2000 |
Thompson AC, Zapata A, Justice JB, Vaughan RA, Sharpe LG, Shippenberg TS. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 9333-40. PMID 11125013 |
0.432 |
|
| 2000 |
Chefer VI, Morón JA, Hope B, Rea W, Shippenberg TS. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine. Neuroscience. 101: 619-27. PMID 11113311 DOI: 10.1016/S0306-4522(00)00417-6 |
0.347 |
|
| 2000 |
Shippenberg TS, Funada M, Schutz CG. Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat. Psychopharmacology. 151: 351-8. PMID 11026742 DOI: 10.1007/s002130000475 |
0.335 |
|
| 2000 |
Schenk S, Partridge B, Shippenberg TS. Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593. Psychopharmacology. 151: 85-90. PMID 10958121 DOI: 10.1007/S002130000476 |
0.324 |
|
| 2000 |
Sharpe LG, Pilotte NS, Shippenberg TS, Goodman CB, London ED. Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain. Synapse (New York, N.Y.). 37: 292-7. PMID 10891866 DOI: 10.1002/1098-2396(20000915)37:4<292::AID-SYN6>3.0.CO;2-V |
0.339 |
|
| 2000 |
Shippenberg TS, Hen R, He M. Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the Serotonin(1B) receptor. Journal of Neurochemistry. 75: 258-65. PMID 10854269 DOI: 10.1046/j.1471-4159.2000.0750258.x |
0.342 |
|
| 2000 |
El Daly E, Chefer V, Sandill S, Shippenberg TS. Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593. Journal of Neurochemistry. 74: 1553-62. PMID 10737612 DOI: 10.1046/j.1471-4159.2000.0741553.x |
0.448 |
|
| 1999 |
Gray AM, Rawls SM, Shippenberg TS, McGinty JF. The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. Journal of Neurochemistry. 73: 1066-74. PMID 10461896 DOI: 10.1046/j.1471-4159.1999.0731066.x |
0.371 |
|
| 1999 |
Chen L, He M, Sibille E, Thompson A, Sarnyai Z, Baker H, Shippenberg T, Toth M. Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B. Journal of Neurochemistry. 73: 647-55. PMID 10428061 DOI: 10.1046/J.1471-4159.1999.0730647.X |
0.428 |
|
| 1999 |
Chefer V, Thompson AC, Shippenberg TS. Modulation of cocaine-induced sensitization by kappa-opioid receptor agonists. Role of the nucleus accumbens and medial prefrontal cortex. Annals of the New York Academy of Sciences. 877: 803-6. PMID 10415709 DOI: 10.1111/j.1749-6632.1999.tb09327.x |
0.347 |
|
| 1999 |
Witkin JM, Savtchenko N, Mashkovsky M, Beekman M, Munzar P, Gasior M, Goldberg SR, Ungard JT, Kim J, Shippenberg T, Chefer V. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 288: 1298-310. PMID 10027871 |
0.311 |
|
| 1998 |
Izenwasser S, Acri JB, Kunko PM, Shippenberg T. Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors. Synapse (New York, N.Y.). 30: 275-83. PMID 9776131 DOI: 10.1002/(Sici)1098-2396(199811)30:3<275::Aid-Syn5>3.0.Co;2-8 |
0.499 |
|
| 1998 |
Heidbreder CA, Schenk S, Partridge B, Shippenberg TS. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist. Synapse (New York, N.Y.). 30: 255-62. PMID 9776129 DOI: 10.1002/(Sici)1098-2396(199811)30:3<255::Aid-Syn3>3.0.Co;2-A |
0.358 |
|
| 1998 |
De Vries TJ, Cools AR, Shippenberg TS. Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization. Neuroreport. 9: 1763-8. PMID 9665597 |
0.34 |
|
| 1998 |
Shippenberg TS, LeFevour A, Thompson AC. Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593. European Journal of Pharmacology. 345: 27-34. PMID 9593590 DOI: 10.1016/S0014-2999(97)01614-2 |
0.326 |
|
| 1997 |
Shippenberg TS, Rea W. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacology, Biochemistry, and Behavior. 57: 449-55. PMID 9218269 DOI: 10.1016/S0091-3057(96)00450-9 |
0.418 |
|
| 1996 |
Funada M, Shippenberg TS. Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats. Behavioural Pharmacology. 7: 448-453. PMID 11224440 |
0.418 |
|
| 1996 |
Shippenberg TS, Heidbreder C, Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. European Journal of Pharmacology. 299: 33-9. PMID 8901005 DOI: 10.1016/0014-2999(95)00852-7 |
0.309 |
|
| 1996 |
Funada M, Schutz CG, Shippenberg TS. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. European Journal of Pharmacology. 300: 17-24. PMID 8741160 DOI: 10.1016/0014-2999(95)00860-8 |
0.389 |
|
| 1996 |
Shippenberg TS, LeFevour A, Heidbreder C. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 276: 545-54. PMID 8632320 |
0.326 |
|
| 1995 |
Shippenberg TS, Bals-Kubik R. Involvement of the mesolimbic dopamine system in mediating the aversive effects of opioid antagonists in the rat. Behavioural Pharmacology. 6: 99-106. PMID 11224316 |
0.45 |
|
| 1995 |
de Vries TJ, Babovic-Vuksanovic D, Elmer G, Shippenberg TS. Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine. Psychopharmacology. 120: 442-8. PMID 8539325 DOI: 10.1007/BF02245816 |
0.323 |
|
| 1995 |
Shoaib M, Spanagel R, Stohr T, Shippenberg TS. Strain differences in the rewarding and dopamine-releasing effects of morphine in rats. Psychopharmacology. 117: 240-7. PMID 7753973 DOI: 10.1007/Bf02245193 |
0.301 |
|
| 1995 |
Shippenberg TS, Heidbreder C. The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. European Journal of Pharmacology. 280: 55-61. PMID 7498254 DOI: 10.1016/0014-2999(95)00185-N |
0.311 |
|
| 1994 |
Spanagel R, Almeida OF, Bartl C, Shippenberg TS. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology. 115: 121-7. PMID 7862883 DOI: 10.1007/Bf02244761 |
0.401 |
|
| 1994 |
Spanagel R, Almeida OF, Shippenberg TS. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. European Journal of Pharmacology. 264: 157-62. PMID 7851478 DOI: 10.1016/0014-2999(94)00449-8 |
0.389 |
|
| 1994 |
Shippenberg T, Heidbreder C. Role of kappa and delta opioid systems in modulating sensitization to the rewarding effects of cocaine Regulatory Peptides. 54: 273-274. DOI: 10.1016/0167-0115(94)90495-2 |
0.424 |
|
| 1993 |
Heidbreder CA, Goldberg SR, Shippenberg TS. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Research. 616: 335-8. PMID 8395306 DOI: 10.1016/0006-8993(93)90228-F |
0.353 |
|
| 1993 |
Spanagel R, Shippenberg TS. Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat. Neuroscience Letters. 153: 232-6. PMID 8392157 DOI: 10.1016/0304-3940(93)90329-J |
0.375 |
|
| 1993 |
Shippenberg TS, Bals-Kubik R, Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. The Journal of Pharmacology and Experimental Therapeutics. 265: 53-9. PMID 8386244 |
0.474 |
|
| 1993 |
Heidbreder C, Goldberg SR, Shippenberg TS. Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole. European Journal of Pharmacology. 243: 123-7. PMID 8276060 DOI: 10.1016/0014-2999(93)90370-W |
0.34 |
|
| 1993 |
Spanagel R, Almeida OF, Shippenberg TS. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse (New York, N.Y.). 14: 243-5. PMID 8211708 DOI: 10.1002/Syn.890140307 |
0.327 |
|
| 1993 |
Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. The Journal of Pharmacology and Experimental Therapeutics. 264: 489-95. PMID 8093731 |
0.411 |
|
| 1993 |
Spanagel R, Herz A, Shippenberg TS. Dopamine release in the mesolimbic system is modulated by opposing endogenous opioid systems Nida Research Monograph Series. 109. |
0.368 |
|
| 1992 |
Ayesta FJ, Ableitner A, Emmett-Oglesby MW, Herz A, Shippenberg TS. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation. The Journal of Pharmacology and Experimental Therapeutics. 260: 168-74. PMID 1731036 |
0.371 |
|
| 1992 |
Herz A, Shippenberg TS, Bals-Kubik R, Spanagel R. [Opiate addiction. Pharmacologic and biochemical aspects]. Arzneimittel-Forschung. 42: 256-9. PMID 1586396 |
0.467 |
|
| 1992 |
Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America. 89: 2046-50. PMID 1347943 DOI: 10.1073/Pnas.89.6.2046 |
0.443 |
|
| 1992 |
Shippenberg TS, Herz A, Spanagel R, Bals-Kubik R, Stein C. Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. Annals of the New York Academy of Sciences. 654: 347-56. PMID 1321576 DOI: 10.1111/J.1749-6632.1992.Tb25980.X |
0.509 |
|
| 1991 |
Spanagel R, Herz A, Bals-Kubik R, Shippenberg TS. Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology. 104: 51-6. PMID 1882003 DOI: 10.1007/Bf02244553 |
0.503 |
|
| 1991 |
Shippenberg TS, Herz A. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands. The Journal of Pharmacology and Experimental Therapeutics. 256: 1101-6. PMID 1848627 |
0.585 |
|
| 1991 |
Shippenberg TS, Bals-Kubik R, Huber A, Herz A. Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacology. 103: 209-14. PMID 1827526 DOI: 10.1007/BF02244205 |
0.567 |
|
| 1991 |
Shippenberg TS. Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors. Neuroscience Letters. 121: 136-8. PMID 1826942 DOI: 10.1016/0304-3940(91)90668-J |
0.382 |
|
| 1991 |
Spanagel R, Herz A, Shippenberg TS. Modulation of the mesolimbic dopaminergic system by beta-endorphin-(1-27) as assessed by microdialysis. European Journal of Pharmacology. 200: 319-24. PMID 1782993 DOI: 10.1016/0014-2999(91)90589-I |
0.451 |
|
| 1991 |
Shippenberg TS, Herz A, Nikolarakis K. Prolonged inflammatory pain modifies corticotropin-releasing factor-induced opioid peptide release in the hypothalamus. Brain Research. 563: 209-14. PMID 1686211 DOI: 10.1016/0006-8993(91)91535-9 |
0.489 |
|
| 1990 |
Spanagel R, Herz A, Shippenberg TS. Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. European Journal of Pharmacology. 190: 177-84. PMID 1981749 DOI: 10.1016/0014-2999(90)94124-G |
0.57 |
|
| 1990 |
Spanagel R, Herz A, Shippenberg TS. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. Journal of Neurochemistry. 55: 1734-40. PMID 1976759 DOI: 10.1111/J.1471-4159.1990.Tb04963.X |
0.607 |
|
| 1990 |
Bals-Kubik R, Shippenberg TS, Herz A. Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. European Journal of Pharmacology. 175: 63-9. PMID 1969799 DOI: 10.1016/0014-2999(90)90153-w |
0.548 |
|
| 1990 |
Herz A, Bals-Kubik R, Spanagel R, Shippenberg T. Neurochemical aspects of opioid addiction European Journal of Pharmacology. 183: 140. DOI: 10.1016/0014-2999(90)91408-4 |
0.575 |
|
| 1990 |
Herz A, Bals-Kubik R, Spanagel R, Shippenberg T. Neurochemical aspects of opioid addiction European Journal of Pharmacology. 183: 140. |
0.324 |
|
| 1990 |
Bals-Kubik R, Shippenberg TS, Herz A. Neuroanatomical substrates mediating the motivational effects of opioids New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 11. |
0.325 |
|
| 1989 |
Emmett-Oglesby MW, Shippenberg TS, Herz A. Fentanyl and morphine discrimination in rats continuously infused with fentanyl. Behavioural Pharmacology. 1: 3-11. PMID 11175382 DOI: 10.1097/00008877-198900110-00002 |
0.477 |
|
| 1989 |
Shippenberg TS, Emmett-Oglesby MW, Herz A. Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity. Pharmacology, Biochemistry, and Behavior. 32: 129-32. PMID 2734325 DOI: 10.1016/0091-3057(89)90221-9 |
0.308 |
|
| 1989 |
Bals-Kubik R, Herz A, Shippenberg TS. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology. 98: 203-6. PMID 2569217 DOI: 10.1007/BF00444692 |
0.582 |
|
| 1989 |
Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. The Journal of Pharmacology and Experimental Therapeutics. 248: 1269-75. PMID 2539460 |
0.395 |
|
| 1988 |
Stein C, Millan MJ, Shippenberg TS, Herz A. Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat. Neuroscience Letters. 84: 225-8. PMID 3340329 DOI: 10.1016/0304-3940(88)90412-0 |
0.493 |
|
| 1988 |
Shippenberg TS, Emmett-Oglesby MW, Ayesta FJ, Herz A. Tolerance and selective cross-tolerance to the motivational effects of opioids. Psychopharmacology. 96: 110-5. PMID 3147470 DOI: 10.1007/BF02431542 |
0.558 |
|
| 1988 |
Bals-Kubik R, Herz A, Shippenberg TS. Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids. Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 392-6. PMID 2854207 DOI: 10.1007/BF00172115 |
0.522 |
|
| 1988 |
Shippenberg TS, Stein C, Huber A, Millan MJ, Herz A. Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonists. Pain. 35: 179-86. PMID 2853321 DOI: 10.1016/0304-3959(88)90225-4 |
0.379 |
|
| 1988 |
Shippenberg TS, Millan MJ, Mucha RF, Herz A. Involvement of beta-endorphin and mu-opioid receptors in mediating the aversive effect of lithium in the rat. European Journal of Pharmacology. 154: 135-44. PMID 2852596 DOI: 10.1016/0014-2999(88)90090-8 |
0.551 |
|
| 1988 |
Shippenberg TS, Herz A. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. European Journal of Pharmacology. 151: 233-42. PMID 2844553 DOI: 10.1016/0014-2999(88)90803-5 |
0.595 |
|
| 1988 |
Shippenberg T, Bals-Kubik R, Herz A. Endogenous opioids and reinforcement: Role of multiple opioid receptor types and dopamine Nida Research Monograph Series. 40. |
0.414 |
|
| 1987 |
Shippenberg TS, Herz A. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. Brain Research. 436: 169-72. PMID 2961413 DOI: 10.1016/0006-8993(87)91571-X |
0.604 |
|
| 1987 |
Shippenberg T, Herz A. Motivational properties of opioids. Polish Journal of Pharmacology and Pharmacy. 39: 577-83. PMID 2852365 |
0.548 |
|
| 1987 |
Shippenberg TS, Bals-Kubik R, Herz A. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Research. 436: 234-9. PMID 2829990 DOI: 10.1016/0006-8993(87)91667-2 |
0.583 |
|
| 1986 |
Shippenberg TS, Herz A. Differential effects of mu and kappa opioid systems on motivational processes. Nida Research Monograph. 75: 563-66. PMID 2829003 |
0.581 |
|
| 1985 |
Shippenberg TS, Altshuler HL. A drug discrimination analysis of ethanol-induced behavioral excitation and sedation: the role of endogenous opiate pathways. Alcohol (Fayetteville, N.Y.). 2: 197-201. PMID 4015843 DOI: 10.1016/0741-8329(85)90045-X |
0.684 |
|
| 1982 |
Altshuler HL, Shippenberg TS. Tetrahydroisoquinoline and opioid substrates of alcohol actions. Progress in Clinical and Biological Research. 90: 329-44. PMID 7202207 |
0.693 |
|
| 1981 |
Altshuler HL, Applebaum E, Shippenberg TS. The effects of opiate antagonists on the discriminative stimulus properties of ethanol. Pharmacology, Biochemistry, and Behavior. 14: 97-100. PMID 7465612 DOI: 10.1016/0091-3057(81)90109-X |
0.68 |
|
| 1981 |
Altshuler HL, Shippenberg TS. A subhuman primate model for fetal alcohol syndrome research. Neurobehavioral Toxicology and Teratology. 3: 121-6. PMID 7254459 |
0.655 |
|
| Show low-probability matches. |